![Michael Dambach](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Dambach
Treasurer bei
BIOGEN INC.
Profil
Michael E.
Dambach is currently Treasurer, Director & Vice President at Stromedix, Inc. and Treasurer & Vice President at Biogen, Inc. since 2010.
Former positions include Treasurer & Director at Bioverativ Therapeutics, Inc., Independent Director at BiomX, Inc. from 2023 to 2024, and Assistant Treasurer at Thermo Fisher Scientific, Inc. Education includes an MBA from Boston University and an undergraduate degree from the University of New Hampshire.
Aktive Positionen von Michael Dambach
| Unternehmen | Position | Beginn |
|---|---|---|
| BIOGEN INC. | Treasurer | 01.01.2010 |
Stromedix, Inc.
 Stromedix, Inc. Pharmaceuticals: MajorHealth Technology Develops novel drugs to treat fibrosis and fibrotic organ failure | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Michael Dambach
| Unternehmen | Position | Ende |
|---|---|---|
| BIOMX INC. | Direktor/Vorstandsmitglied | 15.03.2024 |
| THERMO FISHER SCIENTIFIC, INC. | Corporate Officer/Principal | - |
Bioverativ Therapeutics, Inc.
 Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Direktor/Vorstandsmitglied | - |
Ausbildung von Michael Dambach
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
78
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Bioverativ Therapeutics, Inc.
Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Stromedix, Inc.
Stromedix, Inc. Pharmaceuticals: MajorHealth Technology Develops novel drugs to treat fibrosis and fibrotic organ failure | Health Technology |
Boston University
 Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of New Hampshire
 University of New Hampshire Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Thermo Fisher Scientific, Inc.
 Thermo Fisher Scientific, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and markets analytical and environment monitoring instruments | Health Technology |
BiomX, Inc.
 BiomX, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company developing natural and engineered phage cocktails designed to target and destroy bacteria that affect the appearance of skin | Health Technology |
